Development Pipeline
EA Pharma Co., Ltd. Development Pipeline
as of February, 2025
| Therapeutic Area | Development Code (Generic name) |
Development Stage | Indication | Note |
|---|---|---|---|---|
| Gastrointestinal diseases |
AJG555 | Phase Ⅲ |
Chronic constipation in children under 2 years of age |
Oral |
| AJM347 | Phase I | Inflammatory bowel disease | Oral | |
| EA1080 | Phase I | Inflammatory bowel disease | Oral | |
| EA3571 | Phase I | Nonalcoholic steatohepatitis | Oral |
※スワイプできます
※表は左右にスクロールできます